Adam Levy

Insider Reports History

Location
C/O Miragen Therapeutics, Inc., 6200 Lookout Road, #100, Boulder, CO
Signature
/s/ Adam Levy
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Adam Levy:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mineralys Therapeutics, Inc. CFO and Secretary Common Stock 19.4K $909K $46.88 Nov 11, 2025 Direct
Mineralys Therapeutics, Inc. CFO and Secretary Stock Option 4.89K Nov 11, 2025 Direct

Insider Reports Filed by Adam Levy

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MLYS Mineralys Therapeutics, Inc. Nov 11, 2025 17 -$3.87M 4 Nov 13, 2025 CFO and Secretary
MLYS Mineralys Therapeutics, Inc. Oct 13, 2025 2 -$452K 4 Oct 15, 2025 CFO and Secretary
MLYS Mineralys Therapeutics, Inc. Jul 28, 2025 4 -$1.08M 4 Jul 30, 2025 CFO and Secretary
MLYS Mineralys Therapeutics, Inc. Jul 11, 2025 1 -$155K 4 Jul 15, 2025 CFO and Secretary
MLYS Mineralys Therapeutics, Inc. Apr 11, 2025 1 -$130K 4 Apr 15, 2025 CFO and Secretary
MLYS Mineralys Therapeutics, Inc. Feb 13, 2025 1 $0 4 Feb 24, 2025 CFO and Secretary
MLYS Mineralys Therapeutics, Inc. Jan 13, 2025 2 -$97.9K 4 Jan 15, 2025 CFO and Secretary
MLYS Mineralys Therapeutics, Inc. Oct 11, 2024 1 -$146K 4 Oct 15, 2024 CFO and Secretary
MLYS Mineralys Therapeutics, Inc. Jul 11, 2024 1 -$141K 4 Jul 12, 2024 CFO and Secretary
MLYS Mineralys Therapeutics, Inc. Jun 11, 2024 1 -$1.25M 4 Jun 13, 2024 CFO and Secretary
MLYS Mineralys Therapeutics, Inc. Feb 13, 2024 1 $0 4 Feb 15, 2024 CFO and Secretary
MLYS Mineralys Therapeutics, Inc. Mar 17, 2023 1 $0 4 Mar 21, 2023 CFO and Secretary
MLYS Mineralys Therapeutics, Inc. Feb 14, 2023 1 $100K 4 Feb 16, 2023 CFO, Chief Bus. Off. and Secy.
MLYS Mineralys Therapeutics, Inc. Feb 9, 2023 1 $0 4 Feb 13, 2023 CFO, Chief Bus. Off. and Secy.
MLYS Mineralys Therapeutics, Inc. Feb 9, 2023 0 $0 3 Feb 9, 2023 CFO, Chief Bus. Off. and Secy.